Subject Expert Committee
-
Top News
Bharat Biotech’s Covaxin Gets Nod For Phase 2/3 Trials On 2-18-Yr-Olds: Report
Mumbai: The Central Drugs Standard Control Organisation’s (CDSCO) Subject Expert Committee has reportedly given its nod to Bharat Biotech’s Covaxin…
Read More »